Tech Stock News
Saturday, March 18, 2023
Class action lawsuits are being filed against these four stocks. The investors must have them on their watchlist. Those who are willing to be the plaintiffs in lawsuits must stay tuned in with the law firms and their regular updates for the deadline. ContextLogic Inc (NASDAQ: WISH): Investors’ reminder for […]
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) is under legal investigation and is back in the news. The legal investigation is relating to the proposed merger with Aadi Bioscience, Inc. According to the agreement, shareholders of Aerpio Pharmaceuticals Inc are expected to own 14.7% of the combined company after the closing of […]
ChemoCentryx Inc (NASDAQ: CCXI), now known as Lordstown Motors Corp (NASDAQ: RIDE), is under investigation by Scott+Scott Attorneys at Law LLP. The law firm investigates if a few directors and officials of the company breached their fiduciary duties to DiamondPeak and its shareholders. The timeline of events related to Lordstown […]
Four publicly traded companies are facing class-action lawsuits. This is the investors’ alert. AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) deadline alert AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is facing a class-action lawsuit. Bronstein, Gewirtz & Grossman, LLC is looking into the investigation part of this lawsuit filed against the publicly traded company. […]
Bragar Eagel & Squire, P.C., has prompted stakeholders that class actions have been originated on behalf of stockholders of AcelRx Pharmaceuticals Inc (NASDAQ: ACRX), Ocugen Inc (NASDAQ: OCGN), and Tarena International Inc (NASDAQ: TEDU). Stockholders have until the limits mentioned below to requisition the law court to serve as lead […]
Ocugen Inc (NASDAQ: OCGN), a biopharmaceutical business absorbed on discerning, evolving, and commercializing gene treatments to cure and mounting a vaccine to save exists from COVID-19, today proclaimed that it had nominated Jubilant HollisterStier of Spokane, Washington as its assembling companion for COVAXIN™ to concoct for potentially viable assembling of […]
The stock of Ocugen Inc (NASDAQ: OCGN) dropped by a margin of 5.23% to eventually settle at about 6.34. The Rosen Law Firm suspects that the company misled its investors and has quickly swung into Investigations. Firm’s efforts The law firm expresses concern over the securities claims, outlining that it […]
Despite the late entry into the development of the Covid vaccine, Ocugen Inc (NASDAQ: OCGN) finds its place in the mid-cap space with revenues of $1.87 billion. Investors can buy this stock at $9.70 before Ocugen submits EUA (Emergency Use Application) for its Covid vaccine – Covaxin to the US […]
Bharat Biotech and Ocugen Inc (NASDAQ: OCGN) have agreed to expand the existing Covaxin vaccine commercialization to include other nations. As per the terms of the amended agreement, Ocugen received permission to sell Covaxin vaccines in Canada besides the existing rights in the US. Ocugen’s CEO, Shankar Musunuri, said the […]